In order to enhance transparency, security, and efficiency in the operations of accredited Conformity Assessment Bodies (CABs), the National Accreditation Board for Testing and Calibration ...
In a report released yesterday, Matthew Hedberg from RBC Capital maintained a Buy rating on N-able (NABL – Research Report), with a price target of $10.00. The company’s shares closed ...
In this article, we are going to take a look at where N-able, Inc. (NYSE:NABL) stands against the other IT services stocks. According to research firm Statista, the IT Services industry ...
Scotiabank analyst Joe Vandrick reiterated a Hold rating on N-able (NABL – Research Report) today and set a price target of $8.75. The company’s shares closed yesterday at $7.20. See what ...
Hosted on MSN7mon
Clinitech Laboratory Listing: Stock makes decent market debut, lists at 20% premium at ₹115serology, microbiology, and histopathology. The company has been awarded a Certificate of Accreditation by NABL (National Accreditation Board for Testing and Calibration Laboratories) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback